Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence and characteristics of positional plagiocephaly in healthy full-term infants at 8-12 weeks of life.

European journal of pediatrics·2018

Same author

Serum antibodies from epileptic patients react, at high prevalence, with simian virus 40 mimotopes.

European journal of neurology·2015

Same author

Epidemiology and burden of rotavirus-associated hospitalizations in Ferrara, Italy.

Journal of preventive medicine and hygiene·2007

Same author

Survival and complications in thalassemia.

Annals of the New York Academy of Sciences·2005

Same author

Osteoporosis in beta-thalassemia: Clinical and genetic aspects.

Annals of the New York Academy of Sciences·2005

Same author

Frequency of factor V Leiden in juvenile migraine with aura.

Headache·2001

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Marrow transplantation for thalassemia.

C Borgna-Pignatti

Annual Review of Medicine

|January 1, 1985

Summary

Bone marrow transplantation offers a potential cure for thalassemia major. Early results show a significant portion of children are free of the disease post-transplant, though further advancements are needed.

Area of Science:

Hematology
Pediatric Medicine
Transplantation Immunology

Background:

Thalassemia major is a severe inherited blood disorder with a guarded prognosis despite current treatments.
The need for definitive curative therapies drives research into alternative treatment modalities.
Bone marrow transplantation (BMT) is being explored as a potentially curative option for thalassemia major.

Purpose of the Study:

To evaluate the efficacy and outcomes of bone marrow transplantation in children with thalassemia major.
To assess the survival rates and disease status of thalassemic patients following BMT.

Main Methods:

Retrospective analysis of data from 51 children with thalassemia major who underwent bone marrow transplantation.
Data collected up to May 1984, including disease status and survival at 2 to 30 months post-transplantation.

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Jul 13, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Main Results:

Out of 51 children, 29 were disease-free 2 to 30 months after transplantation.
13 patients died during the follow-up period.
9 patients experienced autologous reconstitution and remained alive with thalassemia.

Conclusions:

Bone marrow transplantation can lead to a thalassemia-free status in a substantial proportion of pediatric patients.
Further improvements in transplantation safety and efficacy are crucial to expand its application to a wider patient population.
BMT holds promise for multiply transfused and hemosiderotic patients who do not benefit from conventional therapies.